Status:
UNKNOWN
The Management of Glucose Control and Hypoglycemic Prevention Using Continuous Glucose Monitoring System in Patients With Type 1 Diabetes
Lead Sponsor:
Yonsei University
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study was designed to evaluate the glucose control and hypoglycemic prevention effect of using continuous glucose monitoring system(CGMS) in patients with type 1 diabetes. This is a prospective r...
Eligibility Criteria
Inclusion
- Male or female patients ages \>= 20 years
- Patients diagnosed with type 1 diabetes.
- Patients with glycated hemoglobin (HbA1c) \> 8.0% within 6 months before screening
- Patients who agree to perform self blood glucose monitoring responsibly during the study period
- Patients diagnosed with type 1 diabetes minimum 3 months prior to recruitment
Exclusion
- Patients diagnosed with type 2 diabetes.
- Patients with chronic disease (Excluding thyroid disorders in which thyroid function is controlled in the normal range), or psychiatric disease
- Patients who cannot use the device properly such as an illiterate person or foreigners
- Patients incapable of making decisions based on their own judgement and will
- A person who may not participate in the study according to investigator's judgement
Key Trial Info
Start Date :
August 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04684030
Start Date
August 28 2020
End Date
August 1 2022
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital Diabetes Center, Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine
Seoul, South Korea